Aldosterone modulates cell proliferation and apoptosis in the neonatal rat heart

Journal of Korean Medical Science

Volumn 25, Issue 9, 2010, Pages 1296-1304

  Sohn, Hyung Joo ^a   Yoo, Kee Hwan ^a   Jang, Gi Young ^a   Lee, Jang Hoon ^a   Choi, Byung Min ^a   Lee, Jung Hwa ^a   Bae, In Sun ^a   Yim, Hyung Eun ^a   Son, Chang Sung ^a   Lee, Joo Won ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Aldosterone; Apoptosis; Cell proliferation; Muscle cells

Indexed keywords

ALDOSTERONE ANTAGONIST; CLUSTERIN; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; METABOLISM; NEWBORN; RAT; SPRAGUE DAWLEY RAT;

ALDOSTERONE ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; CLUSTERIN; FEMALE; HEART; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956503721     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.9.1296     Document Type: Article

References (30)

1. Choi JH, Yoo KH, Cheon HW, Kim KB, Hong YS, Lee JW, Kim SK, Kim CH. Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. Pediatr Res 2002; 52: 325-32.
2. Burniston JG, Saini A, Tan LB, Goldspink DF. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol 2005; 39: 395-9.
3. Veliotes DG, Woodiwiss A, Deftereos DA, Gray D, Osadchii O, Norton GR. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Hypertension 2005; 45: 914-20.
4. Wang W, McClain JM, Zucker IH. Aldosterone reduces baroreceptor discharge in the dog. Hypertension 1992; 19: 270-7.
5. Connell JM, Davies E. The new biology of aldosterone. J Endocrinol 2005; 186: 1-20.
6. Rocha R, Stier CT Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000; 141: 3871-8.
7. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82: 1111-29.
8. Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, Takeda M, Nishikawa S, Yamanaka S, Matoba S, Kobara M, Tanaka H, Shirayama T, Takamatsu T, Nozawa Y, Matsubara H. Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation 2004; 110: 317-23.
9. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-31.
10. Leri A, Fiordaliso F, Setoguchi M, Limana F, Bishopric NH, Kajstura J, Webster K, Anversa P. Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis. Am J Pathol 2000; 157: 843-57.
11. Moses HL, Yang EY, Pietenpol JA. TGF-stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990; 63: 245-7.
12. Gallego M, Espina L, Vegas L, Echevarria E, Iriarte MM, Casis O. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats. Pharmacol Res 2001; 44: 311-5.
13. Barlucchi L, Leri A, Dostal DE, Fiordaliso F, Tada H, Hintze TH, Kajstura J, Nadal-Ginard B, Anversa P. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Circ Res 2001; 88: 298-304.
14. De Angelis N, Fiordaliso F, Latini R, Calvillo L, Funicello M, Gobbi M, Mennini T, Masson S. Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat. J Mol Cell Cardiol 2002; 34: 1655-65.
15. Beinlich CJ, White GJ, Baker KM, Morgan HE. Angiotensin II and left ventricular growth in newborn pig heart. J Mol Cell Cardiol 1991; 23: 1031-8.
16. Struthers AD. Aldosterone-induced vasculopathy. Mol Cell Endocrinol 2004; 217: 239-41.
17. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-54.
18. Engelmann GL, Vitullo JC, Gerrity RG. Morphometric analysis of cardiac hypertrophy during development, maturation, and senescence in spontaneously hypertensive rats. Circ Res 1987; 60: 487-94.
19. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, Wang Y. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 2001; 98: 12283-8.
20. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29: 859-70.
21. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-9.
22. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-6.
23. Pierzchalski P, Reiss K, Cheng W, Cirielli C, Kajstura J, Nitahara JA, Rizk M, Capogrossi MC, Anversa P. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res 1997; 234: 57-65.
24. Hochgrebe TT, Humphreys D, Wilson MR, Easterbrook-Smith SB. A reexamination of the role of clusterin as a complement regulator. Exp Cell Res 1999; 249: 13-21.
25. Zhou W, Janulis L, Park II, Lee C. Novel anti-proliferative property of clusterin in prostate cancer cells. Life Sci 2002; 72: 11-21.
26. Boyer AS, Ayerinskas II, Vincent EB, McKinney LA, Weeks DL, Runyan RB. TGF beta2 and TGF beta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Biol 1999; 208: 530-45.
27. Singla DK, Sun B. Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun 2005; 332: 135-41.
28. Bartram U, Molin DG, Wisse LJ, Mohamad A, Sanford LP, Doetschman T, Speer CP, Poelmann RE, Gittenberger-de Groot AC. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation 2001; 103: 2745-52.
29. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000; 19: 6341-50.
30. Liang Q, Molkentin JD. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 2003; 35: 1385-94.